BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 24308362)

  • 1. Recent advancements of flow cytometry: new applications in hematology and oncology.
    Woo J; Baumann A; Arguello V
    Expert Rev Mol Diagn; 2014 Jan; 14(1):67-81. PubMed ID: 24308362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of flow cytometry in the diagnosis and monitoring of malignant hematological disorders.
    Ward MS
    Pathology; 1999 Nov; 31(4):382-92. PubMed ID: 10643011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Principles of minimal residual disease detection for hematopoietic neoplasms by flow cytometry.
    Wood BL
    Cytometry B Clin Cytom; 2016 Jan; 90(1):47-53. PubMed ID: 25906832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Minimal residual disease in hematology].
    Rák K
    Orv Hetil; 2001 May; 142(21):1091-5. PubMed ID: 11449837
    [No Abstract]   [Full Text] [Related]  

  • 5. Minimal residual disease testing of acute leukemia by flow cytometry immunophenotyping: a retrospective comparison of detection rates with flow cytometry DNA ploidy or FISH-based methods.
    Zwick D; Cooley L; Hetherington M
    Lab Hematol; 2006; 12(2):75-81. PubMed ID: 16751134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring of minimal residual disease in acute leukemia by multiparametric flow cytometry.
    Kusenda J; Fajtova M; Kovarikova A
    Neoplasma; 2014; 61(2):119-27. PubMed ID: 24299307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal residual disease testing in hematologic malignancies and solid cancer.
    Ben Lassoued A; Nivaggioni V; Gabert J
    Expert Rev Mol Diagn; 2014 Jul; 14(6):699-712. PubMed ID: 24938122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical applications of molecular haematology: flow cytometry in leukaemias and myelodysplastic syndromes.
    Dalal BI
    J Assoc Physicians India; 2007 Aug; 55():571-3. PubMed ID: 18019799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal residual disease studies by flow cytometry in acute leukemia.
    Campana D; Coustan-Smith E
    Acta Haematol; 2004; 112(1-2):8-15. PubMed ID: 15178999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technical issues: flow cytometry and rare event analysis.
    Hedley BD; Keeney M
    Int J Lab Hematol; 2013 Jun; 35(3):344-50. PubMed ID: 23590661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometry in hematological disorders.
    Pati HP; Jain S
    Indian J Pediatr; 2013 Sep; 80(9):772-8. PubMed ID: 23943573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality control of flow cytometry data analysis for evaluation of minimal residual disease in bone marrow from acute leukemia patients during treatment.
    Björklund E; Matinlauri I; Tierens A; Axelsson S; Forestier E; Jacobsson S; Ahlberg AJ; Kauric G; Mäntymaa P; Osnes L; Penttilä TL; Marquart H; Savolainen ER; Siitonen S; Torikka K; Mazur J; Porwit A
    J Pediatr Hematol Oncol; 2009 Jun; 31(6):406-15. PubMed ID: 19648789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical uses of flow cytometry in hematological oncology].
    D'Ostilio A; Ginaldi L; Marini L; Di Gennaro A; De Martinis M; Quaglino D
    Recenti Prog Med; 1997 Apr; 88(4):157-65. PubMed ID: 9206811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of hemopoietic cell antigens in flow cytometry.
    Poncelet P; George F; Papa S; Lanza F
    Eur J Histochem; 1996; 40 Suppl 1():15-32. PubMed ID: 8839696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunophenotyping of haematologic malignancies].
    Koehorst SG; Evers H; van Buul T; de Vries F; Haanen C
    Ned Tijdschr Geneeskd; 2004 Sep; 148(38):1861-5. PubMed ID: 15497779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cell transplantation in poor-risk chronic lymphocytic leukemia: assessment of post-transplant minimal residual disease using four- and six-color flow cytometry and allele-specific RQ-PCR.
    Itälä M; Huhtinen AR; Juvonen V; Kairisto V; Pelliniemi TT; Penttilä TL; Rauhala A; Tienhaara A; Remes K
    Eur J Haematol; 2008 Aug; 81(2):100-6. PubMed ID: 18410542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Cytometry on both sides of the Atlantic, 2011.
    Preffer FI; Gratama JW
    Cytometry B Clin Cytom; 2011 Nov; 80(6):373-4. PubMed ID: 22002905
    [No Abstract]   [Full Text] [Related]  

  • 18. [The current status of genetic testing for leukemia].
    Satoh Y; Masuda A; Yokota H; Yatomi Y
    Rinsho Byori; 2014 Apr; 62(4):369-77. PubMed ID: 25022066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometry for hematopoietic cells.
    Krause DS; Delelys ME; Preffer FI
    Methods Mol Biol; 2014; 1109():23-46. PubMed ID: 24473776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical applications of flow cytometry in hematology and immunology.
    McCurley TL; Larson R
    Clin Lab Sci; 1996; 9(6):358-62. PubMed ID: 10165118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.